- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07287579
Comparison Between Platelet Rich Plasma and Nanofat as an Adjuvant Therapy in HairTransplantation
December 3, 2025 updated by: Shenoda Gamel Fayez, Sohag University
Comparison Between Platelet Rich Plasma and Nanofat as an Adjuvant Therapy in Hair Transplantation in Male Androgenic Alopecia
- To compare the efficacy of platlet rich plasma and Nanofat injection as adjuvant therapies with FUE hair transplantation in improving graft survival rate,
- To measure hair density and thickness postoperatively using dermoscopy or trichoscopy.
- To evaluate patient satisfaction and photographic assessment by blinded evaluators.
- To assess any adverse effects or complications related to each modality
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
- Ideal candidates for hair transplantation typically present with a clear, stable pattern of hair loss, characterized by at least 50% thinning or balding in 1 or more areas. The scalp must be healthy, with donor hair of good quality and quantity. Patients must have realistic expectations and be free of medical conditions that compromise surgical outcomes. The safe donor zone is located in the mid-occipital region between the upper and lower occipital protuberances, typically containing 65 to 85 follicular units/cm²
- Intra-operative injection of PRP is beneficial in giving faster density, reducing the catagen loss of transplanted hair, early recovery of the skin, the faster appearance of new anagen hair in FUE hair transplantation.
- This study compares the effects of PRP and Nano fat as adjuvants in Androgenic alopecia patients undergoing FUE hair transplantation.
- Nanofat contain stem cells supposed to improve the results of FUE hair transplantation , but the question that we hope to answer at the end of our study which one we recommend as an adjuvant therapy PRP or Nano fat?
Study Type
Interventional
Enrollment (Estimated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: shenouda Faiez, AL
- Phone Number: 0201285122844
- Email: shenoda011111@med.sohag.edu.eg
Study Contact Backup
- Name: mostafa haredy, MD
- Phone Number: 0201095159392
- Email: mostafaharedy84@gmail.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- 1. Male patients with stable androgenic alopecia more than 2 years. 2. Age 20-50 years 3. No recent medical hair loss treatments.
Exclusion Criteria:
- 1. Active scalp infections or scarring alopecia. 2. Systemic diseases affecting wound healing. 3. Platelet disorders or anticoagulant use. 4. Smoking or heavy alcohol intake
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: group a
hair transplantation done alone without platelet rich plasma or nanofat injection
|
we compare the effect of nanofat injection and platelet rich plasma in hair transplantation in male androgenic alopecia
Other Names:
|
|
Experimental: group b
we do injection of platelet rich plasma with hair transplantation
|
we compare the effect of nanofat injection and platelet rich plasma in hair transplantation in male androgenic alopecia
Other Names:
|
|
Experimental: group c
we do injection of nanofat with hair transplantation
|
we compare the effect of nanofat injection and platelet rich plasma in hair transplantation in male androgenic alopecia
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
• To measure hair density using dermoscopy.
Time Frame: • All patients will be followed up about 6-12 months postoperative.
|
To measure how many hair follicles in each cubic centimetre
|
• All patients will be followed up about 6-12 months postoperative.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: samia saied, MD, Sohag University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
January 1, 2026
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
December 1, 2027
Study Registration Dates
First Submitted
November 22, 2025
First Submitted That Met QC Criteria
December 3, 2025
First Posted (Actual)
December 17, 2025
Study Record Updates
Last Update Posted (Actual)
December 17, 2025
Last Update Submitted That Met QC Criteria
December 3, 2025
Last Verified
November 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Soh-Med--25-11-1MD
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Androgenic Alopecia
-
Galderma R&DCompletedFemale Pattern Hair Loss, Androgenic AlopeciaUnited States
-
Galderma R&DCompletedMale Pattern of Hair Loss, Androgenic AlopeciaUnited States
-
NovoBliss Research Pvt LtdZywie Ventures Privated LtdNot yet recruiting
-
Mohammed Abd El Mawgoud AmerRecruiting
-
Yale UniversityCompletedAndrogenic AlopeciaUnited States
-
Jinan University GuangzhouCompleted
-
Dong-A ST Co., Ltd.CompletedAndrogenic AlopeciaKorea, Republic of
-
Pusan National University HospitalCompleted
-
Dream PlusCompletedAndrogenic AlopeciaKorea, Republic of
-
Sohag UniversityNot yet recruitingAndrogenic Alopecia
Clinical Trials on hair transplantation
-
Nanfang Hospital, Southern Medical UniversityNot yet recruitingLocalized Scleroderma | Fat Grafting | Hair Transplantation
-
NovoBliss Research Pvt LtdCompleted
-
Nutraceutical Wellness Inc.CompletedHair ThinningUnited States
-
Acorn Biolabs Inc.RecruitingRejuvenation | Stem Cell | Facial Aging | Stem Cell BankingUnited States
-
Nemours Children's ClinicNational Institute of General Medical Sciences (NIGMS)Recruiting
-
Nutraceutical Wellness Inc.CompletedHair ThinningUnited States
-
BrandiZoneCitruslabsCompletedHair Loss | Hair HealthUnited States
-
NovoBliss Research Pvt LtdNot yet recruitingHair Fall and Pre-mature Graying
-
Freedom Laser Therapy, Inc.TKL Research, Inc.UnknownAndrogenetic AlopeciaUnited States